Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Johnson & Johnson seeks FDA approval for third use for its new anticlotting drug, Xarelto
Johnson & Johnson seeks FDA approval for third use for its new anticlotting drug, Xarelto
Johnson & Johnson seeks FDA approval for third use for its new anticlotting drug, Xarelto
Submitted by
admin
on December 29, 2011 - 11:52am
Source:
Yahoo/AP
News Tags:
JNJ
FDA
anti-clotting
Xarelto
Headline:
Johnson & Johnson seeks FDA approval for third use for its new anticlotting drug, Xarelto
Do Not Allow Advertisers to Use My Personal information
